These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33096586)

  • 1. Screening for Early-Stage Parkinson's Disease: Swallow Tail Sign on MRI Susceptibility Map-Weighted Images Compared With PET.
    Wang N; Liu XL; Li L; Zuo CT; Wang J; Wu PY; Zhang Y; Liu F; Li Y
    J Magn Reson Imaging; 2021 Mar; 53(3):722-730. PubMed ID: 33096586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Swallow tail sign on susceptibility map-weighted imaging (SMWI) for disease diagnosing and severity evaluating in parkinsonism.
    Liu X; Wang N; Chen C; Wu PY; Piao S; Geng D; Li Y
    Acta Radiol; 2021 Feb; 62(2):234-242. PubMed ID: 32380911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo detection of monoaminergic degeneration in early Parkinson disease by (18)F-9-fluoropropyl-(+)-dihydrotetrabenzazine PET.
    Lin SC; Lin KJ; Hsiao IT; Hsieh CJ; Lin WY; Lu CS; Wey SP; Yen TC; Kung MP; Weng YH
    J Nucl Med; 2014 Jan; 55(1):73-9. PubMed ID: 24287322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical MR imaging in Parkinson's disease: How useful is the swallow tail sign?
    Prasuhn J; Neumann A; Strautz R; Dreischmeier S; Lemmer F; Hanssen H; Heldmann M; Schramm P; Brüggemann N
    Brain Behav; 2021 Jul; 11(7):e02202. PubMed ID: 34032020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of nigrosome 1 in substantia nigra at 3T using multiecho susceptibility map-weighted imaging (SMWI).
    Nam Y; Gho SM; Kim DH; Kim EY; Lee J
    J Magn Reson Imaging; 2017 Aug; 46(2):528-536. PubMed ID: 27859983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using 'swallow-tail' sign and putaminal hypointensity as biomarkers to distinguish multiple system atrophy from idiopathic Parkinson's disease: A susceptibility-weighted imaging study.
    Wang N; Yang H; Li C; Fan G; Luo X
    Eur Radiol; 2017 Aug; 27(8):3174-3180. PubMed ID: 28105503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET.
    Nurmi E; Bergman J; Eskola O; Solin O; Vahlberg T; Sonninen P; Rinne JO
    Synapse; 2003 Jun; 48(3):109-15. PubMed ID: 12645035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Swallow Tail Sign of Substantia Nigra: A Case-Control Study to Establish Its Role in Diagnosis of Parkinson Disease on 3T MRI.
    Gupta R; Kumar G; Kumar S; Thakur B; Tiwari R; Verma AK
    J Neurosci Rural Pract; 2022 Apr; 13(2):181-185. PubMed ID: 35694067
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation of Parkinson disease severity and 18F-DTBZ positron emission tomography.
    Hsiao IT; Weng YH; Hsieh CJ; Lin WY; Wey SP; Kung MP; Yen TC; Lu CS; Lin KJ
    JAMA Neurol; 2014 Jun; 71(6):758-66. PubMed ID: 24756323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing Nigrosome-1 Sign Identification via Interpretable AI using True Susceptibility Weighted Imaging.
    Wang C; He N; Zhang Y; Li Y; Huang P; Liu Y; Jin Z; Cheng Z; Liu Y; Wang Y; Zhang C; Haacke EM; Chen S; Yan F; Yang G
    J Magn Reson Imaging; 2024 Nov; 60(5):1904-1915. PubMed ID: 38236577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomic Features of the Nigrosome-1 Region of the Substantia Nigra: Using Quantitative Susceptibility Mapping to Assist the Diagnosis of Idiopathic Parkinson's Disease.
    Cheng Z; Zhang J; He N; Li Y; Wen Y; Xu H; Tang R; Jin Z; Haacke EM; Yan F; Qian D
    Front Aging Neurosci; 2019; 11():167. PubMed ID: 31379555
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
    Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
    Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial diagnostic workup of parkinsonism: Dopamine transporter positron emission tomography versus susceptibility map-weighted imaging at 3T.
    Sung YH; Lee J; Nam Y; Shin HG; Noh Y; Hwang KH; Lee H; Kim EY
    Parkinsonism Relat Disord; 2019 May; 62():171-178. PubMed ID: 30580909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective multi-centre study of susceptibility map-weighted MRI for the diagnosis of neurodegenerative parkinsonism.
    Sung YH; Kim JS; Yoo SW; Shin NY; Nam Y; Ahn TB; Yoo D; Lee KM; Kim HG; Koh SB; Kim J; Kim I; Kwon DY; Lee Y; Kim C; Chung SJ; Jo S; Lee SH; Kim SJ; Kim M; Lyoo CH; Baek MS; Kang SY; Chang SK; Jo SW; Lee SA; Ma HI; Kim YE; Kim ES; Kim YJ; Kim HS; Woo MH; Choi HJ; Kim EY
    Eur Radiol; 2022 May; 32(5):3597-3608. PubMed ID: 35064313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 99mTc-TRODAT-1 SPECT and 18 F-AV-133 PET imaging in healthy controls and Parkinson's disease patients.
    Hsiao IT; Weng YH; Lin WY; Hsieh CJ; Wey SP; Yen TC; Kung MP; Lu CS; Lin KJ
    Nucl Med Biol; 2014 Apr; 41(4):322-9. PubMed ID: 24503330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nigrosome 1 Detection at 3T MRI for the Diagnosis of Early-Stage Idiopathic Parkinson Disease: Assessment of Diagnostic Accuracy and Agreement on Imaging Asymmetry and Clinical Laterality.
    Noh Y; Sung YH; Lee J; Kim EY
    AJNR Am J Neuroradiol; 2015 Nov; 36(11):2010-6. PubMed ID: 26294646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of Computed Tomography-Guided Methods for Spatial Normalization of Dopamine Transporter Positron Emission Tomography Image.
    Kim JS; Cho H; Choi JY; Lee SH; Ryu YH; Lyoo CH; Lee MS
    PLoS One; 2015; 10(7):e0132585. PubMed ID: 26147749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 6-[
    Michler E; Kaiser D; Eleftheriadou K; Falkenburger B; Kotzerke J; Hoberück S
    EJNMMI Res; 2021 Feb; 11(1):16. PubMed ID: 33590381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
    Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
    Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous Increase of Mean Susceptibility and Mean Kurtosis in the Substantia Nigra as an MRI Neuroimaging Biomarker for Early-Stage Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Mohammadi S; Ghaderi S; Mohammadi H; Fatehi F
    J Magn Reson Imaging; 2024 Aug; ():. PubMed ID: 39210501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.